Prosecutors and regulators have made health care fraud one of their highest priorities.
We help clients navigate the complex maze of regulations covering their day-to-day operations, building compliance programs, conflicts of interest policies and training programs for employees and executives.
When litigation becomes unavoidable, our team of highly skilled trial lawyers achieves favorable results for individuals and companies in some of the nation’s largest and highest profile civil and criminal proceedings—and in all forms of investigations and prosecutions initiated by the Department of Justice, individual U.S. Attorney’s offices and state attorneys general.
We counsel clients on matters including:
We also provide counsel around corporate integrity agreements, and deferred prosecution agreements and other monitorship agreements—helping clients negotiate and, implement and monitor compliance with these agreements and analyzing while managing their impact on our clients’ businesses.
Modern Healthcare | July 28, 2020
In this article on the Department of Health and Human Services Office of Inspector General’s advisory opinion that will expand national nonprofit and client RIP Medical Debt’s services, Long Island Health Care partner Michele Masucci is quoted on the legal nuances of the advisory opinion and anti-kickback concerns.
Law360 | June 25, 2020
This article, covering a federal judge’s dismissal of claims against NP client Bayer Corp. related to the company’s Essure birth control device, mentions Buffalo Complex Commercial Disputes partner Vivian Quinn and counsel Tracey Scarpello for representing Bayer.
IAM | April 02, 2020
Boston Intellectual Property partner Mark FitzGerald discusses how the microbiome—the collection of microbes that occupy the human body—has become an increasingly fruitful source of insights for life sciences researchers looking to develop new therapeutics.
American Health Lawyers Association | April 01, 2020
In this podcast, Washington, D.C. Health Care counsel Sarah Swank speaks with three hospital general counsel on the front lines of the coronavirus pandemic.
AIMed | March 09, 2020
Washington, DC, Health Care counsel Sarah Swank wrote this contributed article analyzing how organizations can avoid fraud and abuse pitfalls as clinical AI services become more prevalent in the industry.
Law360 | March 06, 2020
This article mentions Boston Government Investigations and White-Collar Defense partners Hannah Bornstein and Mark Seltzer for their representation of the defendants in a False Claims Act suit centering on faulty hip replacement devices. The defendants have argued the suit should be dismissed on the grounds that confidential information was used in the complaint.
Modern Healthcare | August 23, 2019
This article quotes Washington, DC, Government Investigations and White Collar Defense partner Adam Tarosky for his perspective on the overlap between anti-kickback violations and False Claims Act violations when physicians are accused of accepted improper perks from medical device companies.
Reuters Legal | July 25, 2019
This story mentions Boston Government Investigations and White Collar Defense partner Mark Seltzer for his representation of GlaxoSmithKline in an ongoing matter regarding the drugmaker’s antinausea medication, Zofran.
Health Law Alert | 12.03.20
Life Sciences Alert | 08.27.20
Health Care | 06.30.20
Health Care | 03.04.20
Environment Law Alert | 06.18.19
Government Investigations & White Collar Defense Alert | 11.20.18
Litigation Alert | 11.15.18